Washington University in St Louis (WUSTL) has just received a $2M research grant that will go towards combating a disorder which afflicts, often fatally, nearly 5.8 million Americans each year: heart failure. Heart failure is one of the leading causes of death in the US and although many promising drugs have been introduced over the years, we have yet to find a definitive treatment for the variety of cases that doctors encounter. This $2M NIH award wil go to a team of WUSTL scientists for basic research that will contribute to our understanding of heart disease and ideally lead to more effective treatment. The end goal of this research project is the design and construction of artificial tissue models of the heart, which will allow scientists to more quickly and efficiently test new drugs.
Science Market Update
Tags: Bioscience research, Midwest, biomedical sciences, biomedical research, Bioresearch, Washington University, Missouri, WUSTL, heart disease, 2012, Biochemistry, BioResearch Product Faire Event, Research, NIH, MO, St Louis, BRPF, basic research funding
University expansion is never uncomplicated, especially in an urban environment where density is high, real estate is ultra-expensive, and development is intensely regulated. Yet new buildings do go up in places like New York City if you have the drive, wealth, and reputation of an institution like Columbia University, which is currently constructing not only new buildings but an entirely new campus to expand its academic and research programs. In addition to the original Morningside Heights location and the Medical School campus in Washington Heights, Columbia has purchased and is building a new campus in the "Manhattanville" neighborhood, stretching from 125th Street to 133rd Street in West Harlem.
Tags: biomedical sciences, Northeast, Biomedical expansion, New research facilities, New York, Columbia University, 2012, Neuroscience, Columbia, BioResearch Product Faire Event, NY, new construction, NYC campus competition
Biomedical science researchers have worked tirelessly at the University of California, Riverside since the discovery of a crucial link involving mice, humans, and Alzheimer's disease. Back in 2006, UCR researchers, in a collaborative effort with the University of South Florida, discovered an interesting connection between the immune system and Alzheimer's disease while experimenting on lab mice. Professor Douglas Ethell, the assistant professor of Biomedical Sciences at UCR, along with the USF's own Professor Gary Arendash of the Johnnie B. Byrd Institute, was instrumental in this find.
The first construction of an image by Nuclear Magnetic Resonance (NMRI) by Dr. Paul Lauterbur took place at the University at Stony Brook thirty years ago, and the Stony Brook Chemistry professor went on to win the 2003 Nobel Prize for his work. So it's fitting that another breakthrough in MRI technology is also taking place at the Long Island research university, this time by biomedical engineer Balaji Sitharaman, right, and his team, who have developed a potentially safer and more cost effective MRI contrast agent for improved disease diagnosis and detection. The agent is graphene-based rather than gadolinium-based, and the success of the advanced agent is documented in a recent PLoS ONE article.
Tags: biomedical sciences, biomedical research, Northeast, New York, Stony Brook University, venture development in life sciences, BioResearch Product Faire Event, Biomedical Research Funding, scientist solutions, life science products, science solution
The UC Davis Cancer Center was recently recognized as a "comprehensive" center by the National Cancer Institute (NCI). This is the most prestigious honor that a cancer center can receive and designates the renamed, UC Davis Comprehensive Cancer Center as one of the top cancer research institutions in the country.
Tags: biomedical sciences, University of California Davis, cancer research, Southwest, California, UC Davis Cancer Center, BioResearch Product Faire Event, BRPF, Biomedical Research Funding, Cancer Center, Sacramento Campus
A new science building and facility expansion are in the works at Texas A&M. On February 9th, the University System Board of Regents approved a $120 million building and facility expansion for the College of Veterinary Medicine and Biomedical Sciences in College Station, Texas. The new building will house high-tech laboratories and classrooms that are expected to facilitate learning by offering a superior science research atmosphere.